SOURCE: Press Ventures

September 17, 2013 09:00 ET

Press Ventures and Biosafety Systems Announce Appointment of V.P. of Asian Business Development

WARSAW, POLAND--(Marketwired - Sep 17, 2013) - Press Ventures Inc. (OTCQB: PVEN) ("Press Ventures" or the "Company") and its wholly-owned Polish subsidiary Biosafety Systems, Inc. Sp z o.o., is pleased to announce that it has appointed Mrs. Lili Góralczyk as its new Vice-President of Asian Business Development.

Mrs. Góralczyk has extensive experience as an expert Asian business consultant, diplomat, and journalist. "We are very pleased to have added Lili Góralczyk to our operations team where she will oversee expansion into the Asian markets where the need and demand for our all-natural patented Cedar Leaf Oil Diffusion biosafety technology is the most obvious," stated Mr. Edward Denkiewicz, Press Ventures CEO. "Lili's previous work in China with high-growth European companies along with her diplomatic history and journalism background will all be of strategic importance to the Company going forward." Mrs. Góralczyk was born in China, the daughter of Dr. Zdzislaw Góralczyk, a longtime Polish Ambassador to China, Honorary Citizen of Beijing, and the current President of the Polish Friendship Society - China.

Most recently, from 2010 to 2013, she was an advisor to Ostcommerce, an Austrian company with interests in China. From 2007 to 2010, Góralczyk provided China and Asian advisory services to Bioton, one of the largest genetic insulin producers in Europe. From 2003 to 2007, Lili was based in the Polish Consulate in Moscow where she worked within the Ministry of Foreign Affairs. Prior to her diplomatic position in Moscow, Mrs. Góralczyk worked with Shanghai Intercommerce in Shanghai as Commercial Director (2000-2002), as China market advisor to the board of Novomatic (1992-2000), and as Chinese language translator in Shanghai with Chipobrok, a Polish/Chinese shipbuilding company (1988-1992). Mrs. Góralczyk is also an accomplished journalist in Poland as editor of "Life of Warsaw" (1983-1988) and as editor of Gazeta Wyborcza ("Agora") -- the biggest daily newspaper in Poland (1988). Mrs. Góralczyk is fluent in Chinese, Russian, English, and Polish. She completed high school at the Soviet Embassy in Beijing, studied Sinology (the study of Chinese language and culture) at the Moscow Institute of the Far East, and graduated from the University of Warsaw's Faculty of Sinology in 1992.

About Press Ventures
Press Ventures holds the worldwide rights to the patented Cedar Leaf Oil Diffusion ("CLO-D") technology for the use of natural products to kill bacteria, mold, and viruses in buildings. The patented CLO-D technology has been shown to be capable of killing many deadly bacterial and viral substances such as anthrax and H1N1 in buildings while they are still occupied. The CLO-D technology has been laboratory and field tested and the Company believes that use of the technology can provide a marked improvement in air quality and eliminate many of the most dangerous airborne bacteria, viruses, and pollutants. For additional information about CLO-D technology and Press Ventures, please visit

Notice Regarding Forward-Looking Statements
This news release contains "forward- looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release that are not purely historical are forward- looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, demand for natural biosafety solutions, exploitation of business opportunities, expansion into Asia, strategic business goals, rise in diseases, capability of the Company's technology, improvement in air quality and elimination of many of the most dangerous airborne bacteria, viruses, and pollutants and market information. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products or technologies and operating as a development stage company, our ability to retain important members of our management team and attract other qualified personnel, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, our ability to develop and commercialize products based on our technology platform, and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward- looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at

Contact Information